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Background
The phenotypic properties of embryonic and adult stem
cells are largely mediated by epigenetic modifications which
control stemness, multipotentiality and fate specification. In
this study, our objective was to identify the epigenetic
mechanism regulating the growth and differentiation of
human cardiac stem cells (hCSCs).
Materials and methods
Discarded surgical specimens were enzymatically
digested and c-kit-positive hCSCs were sorted by FACS.
Results
Genome-wide analysis of histone modifications docu-
mented that adult hCSCs are characterized by a bivalent
chromatin configuration similar to that of embryonic
stem cells with repressive and activating marks at lysine
residues of histones H3 and H4. The high levels of
di-(H3K4me2) and tri-methylation (H3K4me3) at lysine
4 of histone H3 prompted us to test the function of his-
tone methyltransferase Smyd3, which is downregulated
by the non-functional mutation in the c-kit receptor, in
hCSCs. Inhibition of Smyd3 by siRNA strategy decreased
the fraction (60%) of cycling hCSCs and increased apop-
tosis (2.5-fold). Attenuation of hCSC growth was coupled
with a decline in the expression of telomerase, hTERT,
and the myocyte specific transcription factors hNkx2.5
and hGata6. By immunolabeling, Smyd3 co-localized
with hTERT, hNkx2.5 and hGATA6 in hCSC nuclei.
Conversely, transfection of hCSCs with a plasmid
carrying Smyd3 was coupled with upregulation of hTERT
and hNkx2.5. Chromatin immunoprecipitation assay
show that Smyd3 binds to hTERT, hGata6 and hNkx2.5
promoter regions that contains the putative binding sites
for Smyd3. Moreover, the mutations at the Smyd3 DNA
binding sites, decreased the promoter activity of hTERT
and hGata6. Smyd3 siRNA treatment decreased the
reporter activity of luciferase reporter plasmids contain-
ing hTERT.
Conclusions
Our results show that Smyd3 represents a crucial epige-
netic modulator of hCSC commitment to the myocyte
lineage.
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